Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NVH Medicinal logo — La révolution du collagène de synthèse

NVH Medicinal

La révolution du collagène de synthèse

Founded 2008 3 employees Biotechnology

General Information

Company Name NVH Medicinal
Founded Year 2008
Employees 3
Industries Biotechnology
Social

Get notified when NVH Medicinal moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NVH Medicinal

NVH Medicinal is a biotechnology company based in Dijon that was founded in 2008. The company's mission is to address pathologies related to collagen deficiency by developing products derived from collagen, the most abundant protein in the body. These products aim to tackle a range of diseases, including aging, cardiovascular, inflammatory, neurological, fibrosis, cancer, and rare diseases. NVH's ambition is to establish itself as an innovative player in collagen-related disease treatment and become a global leader in the development, production, and commercialization of a new family of recombinant proteins derived from collagen, called collagen analogs or synthetic collagens that hold promise for treating various ailments. As of now, there is no public information available about NVH Medicinal's last investment or the involved investors. However, the company's commitment to addressing critical medical needs through biotechnological advancements makes it an intriguing prospect for potential venture capital interest. With its focused approach on collagen deficiency-related diseases and advanced biotechnological solutions, NVH Medicinal presents an attractive opportunity for investors seeking to support innovative advancements in the biotechnology industry.

Taxonomy: Collagen treatment, Protein engineering, Biomanufacturing, Biochemical analysis, Biomedical research, Therapeutic proteins, Recombinant proteins, Drug development, Disease treatment, Life sciences, Biomedical technology, Biopharmaceuticals

No funding data available for NVH Medicinal yet.

Get notified when NVH Medicinal raises funding

NVH Medicinal Alternatives & Competitors

NVH Medicinal vs
INNOTHERA
INNOTHERA France

La santé au quotidien pour tous

814 employees
Health Care, Medical Devices

FAQ About NVH Medicinal

La révolution du collagène de synthèse
NVH Medicinal was founded in 2008.
NVH Medicinal operates in the following industries: Biotechnology.
NVH Medicinal has approximately 3 employees.
Top alternatives and competitors to NVH Medicinal include INNOTHERA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NVH Medicinal and INNOTHERA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NVH Medicinal and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy